文献速递肺结节与肺癌

肺癌治疗延迟对生存的影响

Impact of Delays in Lung Cancer Treatment on Survival.
PubMed 文献 · Chest · 2021-08-20

本文综述现有文献,探讨肺癌治疗延迟对生存的影响。研究发现研究间异质性显著,常出现延迟与晚期患者生存改善相关的悖论结果,多归因于方法学缺陷。延迟效应可能因分期而异,目前无法精确量化。

要点

  • 延迟对生存的影响可能因分期不同而异。
  • 亚厘米结节影响最小,II期可能最大,仅姑息治疗者影响小。
  • 现有时限性质量指标应关注局部障碍并考虑初始临床-影像分期。

核心结论

  • 延迟对肺癌生存的影响因分期而异,目前无法精确量化。
  • 许多研究存在方法学缺陷,可能导致悖论性结果。

研究设计与样本

  • 本文为文献综述,回顾现有关于肺癌治疗延迟与生存关系的研究。

主要发现

  • 研究间关于延迟影响的异质性显著,常报告悖论性结果。
  • 晚期患者中延迟与生存改善相关的结果常见,但可能源于方法学缺陷。
  • 延迟对生存的影响可能因分期不同而变化。

关键数值与推荐

  • 延迟对亚厘米结节影响最低,对II期疾病可能最高,对仅适合姑息治疗者影响低。

临床怎么用

  • 肺癌时限性质量指标应关注局部障碍,并考虑初始临床-影像分期。

局限性

  • 许多研究错误控制最终病理分期、未控制癌症表现急缓的混杂、未考虑效应测量修饰。
  • 目前无法精确量化延迟对生存的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Timely care is an important dimension of health care quality, but the impact of delays in care on lung cancer outcomes is unclear. Quantifying the impact of delays in cancer treatment on survival is necessary to inform resource allocation, quality improvement initiatives, and lung cancer guidelines. Review of the available literature demonstrated significant heterogeneity between studies in terms of the impact of delay. Frequently paradoxical results were reported, with delay being associated with improved survival in patients with advanced disease. However, significant methodologic flaws were identified in many studies, which probably is the reason for the paradoxical results. The most significant methodologic limitations identified were incorrectly controlling for final pathologic stage (a mediator in the causal chain from delay to survival), failure to control for confounding by acuity of cancer presentation, and failure to consider effect measure modification. The effect of delay on survival probably varies by stage. The impact of delays is lowest for subcentimeter nodules, probably highest in stage II disease, and low in patients who are only eligible for palliative care. Precise quantification of the impact of delay is not currently possible. Given the available evidence, quality metrics for the timeliness of lung cancer care should focus on local barriers to care. These metrics should be carefully designed to take into account clinical-radiographic stage at initial presentation.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Zuniga PVS, Ost DE. Impact of Delays in Lung Cancer Treatment on Survival. Chest. 2021. PMID: 34425080. doi:10.1016/j.chest.2021.08.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。